Saudi Arabia's Pharma Market Is 'Open For Business'
This article was originally published in Scrip
Saudi Arabia could be an exciting market for many pharmaceutical companies looking to grow their business. Not only is it the biggest market in the Gulf, worth $5.1bn in 2012, but it is also an important gateway for other markets in a region where demand is steadily growing. And now new developments at the Saudi Food & Drugs Authority (SFDA) means that firms will likely find it easier to get to the market, explains Hassaan Alwohaibi, director of product licensing at the SFDA's drug division.
Register for our free email digests: